Compare
Milestone Scientific Inc. vs LogicMark, Inc. vs Lifeward Ltd. vs ENvue Medical, Inc.
| Latest fiscal year | Milestone Scientific Inc. MLSS | LogicMark, Inc. LGMK | Lifeward Ltd. LFWD | ENvue Medical, Inc. FEED |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $8.97M | $11.43M | $22.03M | $2.55M |
| Revenue growth (YoY) | +4.0% | +15.4% | -14.1% | -0.2% |
| Gross margin | 71.4% | 66.8% | 38.2% | 6.0% |
| Operating margin | -63.5% | -69.1% | -89.3% | -896.6% |
| Net margin | -63.8% | -65.4% | -90.4% | -712.3% |
| Net income | -$5.72M | -$7.47M | -$19.91M | -$18.18M |
| EPS (Diluted) | -$0.07 | -$13.06 | -$17.16 | -$26.69 |
| Operating cash flow | -$2.92M | -$5.06M | -$16.83M | -$9.37M |
| Free cash flow | -$2.93M | -$5.13M | -$16.84M | -$9.43M |
| Cash & equivalents | $1.11M | $3.57M | $2.17M | $4.22M |
| Total assets | $7.81M | $20.31M | $22.90M | $41.12M |
| Total liabilities | $4.99M | $2.22M | $14.49M | $7.63M |
| Shareholders' equity | $2.81M | $16.28M | $8.41M | $33.50M |
| Return on year-end equity | -203.4% | -45.9% | -236.8% | -54.3% |
| Shares outstanding | 80.45M | 906.1K | 1.52M | 1.10M |
Revenue, most recent five fiscal years
| Fiscal year | Milestone Scientific Inc. | LogicMark, Inc. | Lifeward Ltd. | ENvue Medical, Inc. |
|---|---|---|---|---|
| Latest | $8.97M Ended 2025-12-31 | $11.43M Ended 2025-12-31 | $22.03M Ended 2025-12-31 | $2.55M Ended 2025-12-31 |
| 1 year earlier | $8.63M Ended 2024-12-31 | $9.90M Ended 2024-12-31 | $25.66M Ended 2024-12-31 | $2.56M Ended 2024-12-31 |
| 2 years earlier | $9.83M Ended 2023-12-31 | $9.93M Ended 2023-12-31 | $13.85M Ended 2023-12-31 | $2.28M Ended 2023-12-31 |
| 3 years earlier | $8.81M Ended 2022-12-31 | $11.92M Ended 2022-12-31 | $5.51M Ended 2022-12-31 | $752.0K Ended 2022-12-31 |
| 4 years earlier | $10.30M Ended 2021-12-31 | $10.02M Ended 2021-12-31 | $5.97M Ended 2021-12-31 | $1.70M Ended 2021-12-31 |